1. Home
  2. COEP vs WAI Comparison

COEP vs WAI Comparison

Compare COEP & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • WAI
  • Stock Information
  • Founded
  • COEP 2017
  • WAI 2018
  • Country
  • COEP United States
  • WAI China
  • Employees
  • COEP N/A
  • WAI 85
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • WAI
  • Sector
  • COEP Health Care
  • WAI
  • Exchange
  • COEP Nasdaq
  • WAI NYSE
  • Market Cap
  • COEP 27.4M
  • WAI 8.1M
  • IPO Year
  • COEP N/A
  • WAI 2023
  • Fundamental
  • Price
  • COEP $9.47
  • WAI $0.48
  • Analyst Decision
  • COEP
  • WAI
  • Analyst Count
  • COEP 0
  • WAI 0
  • Target Price
  • COEP N/A
  • WAI N/A
  • AVG Volume (30 Days)
  • COEP 37.4K
  • WAI 1.8M
  • Earning Date
  • COEP 08-15-2025
  • WAI 08-24-2025
  • Dividend Yield
  • COEP N/A
  • WAI N/A
  • EPS Growth
  • COEP N/A
  • WAI N/A
  • EPS
  • COEP N/A
  • WAI N/A
  • Revenue
  • COEP $62,874.00
  • WAI $3,750,352.00
  • Revenue This Year
  • COEP N/A
  • WAI N/A
  • Revenue Next Year
  • COEP N/A
  • WAI N/A
  • P/E Ratio
  • COEP N/A
  • WAI N/A
  • Revenue Growth
  • COEP N/A
  • WAI N/A
  • 52 Week Low
  • COEP $2.31
  • WAI $0.44
  • 52 Week High
  • COEP $13.70
  • WAI $20.00
  • Technical
  • Relative Strength Index (RSI)
  • COEP 62.24
  • WAI N/A
  • Support Level
  • COEP $7.25
  • WAI N/A
  • Resistance Level
  • COEP $9.90
  • WAI N/A
  • Average True Range (ATR)
  • COEP 0.63
  • WAI 0.00
  • MACD
  • COEP 0.26
  • WAI 0.00
  • Stochastic Oscillator
  • COEP 85.62
  • WAI 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About WAI TOP KINGWIN LTD

Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).

Share on Social Networks: